Related Experiment Video
Updated: Feb 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypoglycemia Reduction Strategies in the ICU
Susan Shapiro Braithwaite1,2, Dharmesh B Bavda3, Thaer Idrees3
1, 1135 Ridge Road, Wilmette, IL, 60091, USA. susan.s.braithwaite@gmail.com.
Minimizing hypoglycemia risk in intensive care units (ICUs) involves careful insulin dosing, glucose monitoring, and managing external factors. Proactive strategies are crucial for preventing hypoglycemia and improving patient outcomes.
Area of Science:
- Critical care medicine
- Endocrinology
- Clinical pharmacology
Background:
- Hypoglycemia in the ICU is linked to increased patient mortality.
- Effective glucose management is essential for critically ill adults.
Purpose of the Study:
- To review strategies for reducing hypoglycemia risk in critically ill non-pregnant adult patients.
- To identify key factors influencing hypoglycemia in the ICU setting.
Main Methods:
- Literature review of studies on hypoglycemia risk reduction in ICUs.
- Analysis of factors including insulin dosing, glucose monitoring, and external influences.
Main Results:
- Insulin dosing protocols, glucose monitoring, and computerized systems impact hypoglycemia risk.
- Strategies like IV insulin boluses for insulin resistance and managing carbohydrate exposure are important.
- Adjusting antihyperglycemic therapy for renal impairment and considering medication interactions are critical.
Conclusions:
- Caregivers must establish clear protocols for insulin therapy, carbohydrate exposure, and medication management.
- System-wide quality improvement initiatives should prioritize hypoglycemia prevention in ICUs.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Oral Hypoglycemic Agents: Glinides
Dipeptidyl Peptidase 4 Inhibitors
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

